FMT

Clinicians now have two approved options for recurrent infections after antibiotic treatment.

Poo donations are being used to treat a deadly gut infection, with trials recording a huge cure rate. Donors say its easier than giving blood, but there's not enough of them.

Discover the ground-breaking science behind the microbiome with the Microbiome Mavericks audiobook. Featuring leading experts in the field, this audiobook takes you on a journey through the intricate world of microbiota and its impact on human health. With fascinating insights and real-world examples, you’ll learn how to optimize your microbiome for optimal health and well-being. Whether you’re a health enthusiast or a medical professional, the Microbiome Mavericks audiobook is a must-listen. Listen or download your copy today and take the first step towards a healthier, happier you.

In allogeneic HCT recipients and patients with AML, third-party FMT was safe and ameliorated intestinal dysbiosis, but did not decrease infections. Novel findings from this trial will inform future development of FMT trials.

Clostridioides difficile infection (CDI) is a pressing health care issue due to the limited effectiveness of current treatments and high recurrence rates. Current available antibiotic options for CDI disrupt the fecal microbiome which predisposes recurrent CDI. Fecal microbiota transplantatio …

The U.S. Food and Drug Administration (FDA) has approved VOWST, a microbiota-based therapeutic to prevent recurrence of C. difficile Infection (CDI) in adults following antibacterial treatment for recurrent CDI (rCDI). The approval was based on clinical trials run by UC Davis Health Chief of Infectious Diseases Stuart Cohen.

Clostridioides difficile is a gram-positive, spore-forming, obligate anaerobe that infects the colon. C. difficile is estimated to cause nearly half a million cases in the United States annually, with about 29,000 associated deaths. Unfortunately, the current antibiotic treatment is no …

Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by hyperglycemia and insulin resistance. The incidence of T2DM is increasing globally, and a growing body of evidence suggests that gut microbiota dysbiosis may contribute to the development of this disease. Gut microbiota-derived …

Fecal microbiota transplantation (FMT) is an emerging and effective therapy for the treatment of inflammatory bowel disease (IBD). Previous studies have reported that compared with FMT, whole intestinal microbiota transplantation (WIMT) can more precisely replicate the community structure and reduce …

Clostridioides difficile is a gram-positive, spore-forming, obligate anaerobe that infects the colon. C. difficile is estimated to cause nearly half a million cases in the United States annually, with about 29,000 associated deaths. Unfortunately, the current antibiotic treatment is no …

In this post, we ask whether dietary interventions, prebiotics, probiotics and medication that target the microbiome are useful for weight management.

The 11th Gut Microbiota for Health World Summit focused on emerging gut microbiome-targeted treatments in digestive, immune and cardiometabolic health. This post highlights the major take-aways from the conference and explores how they might impact clinical practice in the foreseeable future.

it is noted that FMT favors the response of melanoma to immunotherapy, translated into significant clinical benefit. However, further studies are necessary for the complete elucidation of the bacteria and the mechanisms involved, as well as for the translation of new evidence to oncological care pra …

Last week at IMMUNOLOGY2023, the 106th annual meeting hosted by The American Association of Immunologists, our computational modeling partner, The NIMML…

ICYMI! 📢📢📢This CE webinar on C. difficile and Microbiome Restoration with @kristadgens and @anniejayTX is still available! Check it out!https://t.co/GsmED4Mqt3#Cdiff #CDI #IDTWitter #TwitteRx pic.twitter.com/fHIAq55rsO— SIDP (@SIDPharm) May 23, 2023

Antimicrobial resistance (AMR) is one of the greatest challenges facing humanity, causing a substantial burden to the global healthcare system. AMR in Gram-negative organisms is particularly concerning due to a dramatic rise in infections caused by extended-spectrum beta-lactamase and carbapenemase- …

Alzheimer's disease (AD) is the most common neurodegenerative disease, yet it currently lacks effective treatment due to its complex etiology. The pathological changes in AD have been linked to the neurotoxic immune responses following aggregation of Aβ and phosphorylated tau. The gut microbiota (GM …

RBX2660 showed similar efficacy and safety in treating patients with and without immunocompromised conditions.

/PRNewswire/ -- Prior to Ferring Pharmaceuticals' Rebyota, physicians interested in using fecal microbiota transplants (FMT) to treat patients with recurrent...

📢 Hiring now!We're expanding our 5-year IBD microbial manipulation research program in Adelaide🥦💩🦠✅Post-doc scientist ✅ Trial coordinator#microbiome #Diet #IBD #FMTEnquires to A/Prof Rob Bryant @RobVBryant or Dr Alice Day @Alice_APD https://t.co/Q5UEbBXSF3 pic.twitter.com/U1bjmZpix7— Dr Alice Day (@Alice_APD) May 23, 2023

Fecal microbiota transplants are the most effective and affordable treatment for recurrent infections with Clostridioides difficile, an opportunistic bacterium and the most common cause of hospital-acquired intestinal infections. However, attempts to treat chronic noncommunicable diseases such as ulcerative colitis and metabolic syndrome via fecal microbiota transplantation (FMT) have yielded mixed results.

While clinical trials may be most closely associated with cancer research, two experts with Sanford Health say the impacts are far more widespread in the medical field.

The researcher discusses the findings in a new study on the efficacy and safety of fecal microbiota (REBYOTA™), the first microbiota-based live biotherapeutic

In this limited series, efficacy of FMT in pediatric SOT is comparable to efficacy in the general pediatric recurrent CDI population. There may be an increased risk of procedure-related SAE in SOT patients and larger cohort studies are needed.

Live fecal microbiota oral capsules (Vowst) for prevention of CDI recurrence

On the brink of innovative science and biotechnology, Seres Therapeutics, Inc. (NASDAQ:MCRB) is a company that is making waves. With

“We want to develop a fecal microbial transplantation (FMT)-based treatment in the form of an oral capsule with a defined set of purely cultivated microbes to address the downfalls of FMT,” said the winner of the proof-of-concept study at a microbiome conference.Korea Biomedical Review (KBR) spoke w

In this limited series, efficacy of FMT in pediatric SOT is comparable to efficacy in the general pediatric recurrent CDI population. There may be an increased risk of procedure-related SAE in SOT patients and larger cohort studies are needed.

There were no differences in the number of relapses between the study groups at the 12-mo follow-up. Thus, our results do not support the use of a single-dose FMT for the maintenance of remission in UC.

A crypt autochthonous microbial population called crypt-associated microbiota (CAM) is localized intimately with gut regenerative and immune machinery. The present report utilizes laser capture microdissection coupled with 16S amplicon sequencing to characterize the CAM in patients with ulcerative c …